Thus, it is plausible that the impact of DHA on macrophage related to NAFLD/NASH pathogenesis can be explained by the fact that DHA simultaneously limits cell access to BTC and TLR2/4 agonists. This evidence concerns the gene TLR2 and metabolic dysfunction-associated steatohepatitis.